Sec. 5. 22 MRSA c. 556 is enacted to read:

CHAPTER 556

MAINE METH WATCH PROGRAM

§2351. Maine Meth Watch Program

1.__Establishment; purpose.__The Office of Substance Abuse shall establish the Maine Meth Watch Program to educate retailers, retail employees and the public in order to help curtail suspicious sales and the theft of methamphetamine precursor drugs as defined in Title 17-A, section 1101, subsection 4-A and to identify the location of illicit methamphetamine manufacturing.

2.__Rulemaking.__The Office of Substance Abuse may adopt rules to carry out the purposes of this chapter. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A.

Sec. 6. 32 MRSA §13702, sub-§25-B is enacted to read:

25-B.__Targeted methamphetamine precursor.__"Targeted methamphetamine precursor" means any product containing any amount of ephedrine, pseudoephedrine or phenylpropanolamine or their salts, isomers or salts of isomers, either alone or in combination with other ingredients:

A.__In dry or solid nonliquid form; or

B.__In liquid, liquid-filled capsule or glycerin matrix form if designation as a targeted methamphetamine precursor has been completed by rule adopted pursuant to section 13795, subsection 5, paragraph A.

Sec. 7. 32 MRSA §13795, as amended by PL 1997, c. 437, §46, is further amended to read:

§13795. Photographic proof of identification; discretion to sell

or dispense; immunity

1. Photographic proof of identification. As a precondition to filling any prescription or, dispensing any drug or selling any targeted methamphetamine precursor, a pharmacist or person acting at the direction of a pharmacist may demand, inspect and